Dr. Marshall, who is board certified in Internal Medicine and Pulmonary Disease, is Senior Vice President for Clinical Affairs at the Cystic Fibrosis (CF) Foundation. He joined the organization in 2002 and directs the clinically related activities of the foundation including the care center network, quality improvement, clinical practice guidelines, patient registry and educational resources.

From 1988 to 2002, Dr. Marshall served as a faculty member at the University of Utah School of Medicine and advanced to the rank of Associate Professor of Medicine with tenure. He also served as Director of the Adult CF Program from 1989 to 2002 and established one of the leading adult programs in the country. His research interests have centered on CF-related epidemiologic and clinical research and include the development of survival models and their application to an analysis of the impact of lung transplantation, and the role of chronic azithromycin in the treatment of CF.

Paul G. Kluetz, M.D., is the Associate Director of Clinical Science in the Office of Hematology and Oncology Products (OHOP) and the Acting Associate Director of Patient Outcomes in the Oncology Center of Excellence at the U.S. Food and Drug Administration. Originally, he focused on genitourinary cancers and played a key role in the review of several important novel prostate cancer therapies. He later served as Acting Deputy Director of OHOP.

Dr. Kluetz has developed expertise in several areas of regulatory science and policy. In 2016, he took a permanent position as Associate Director of Clinical Science within the OHOP Immediate Office, and more recently has been assigned to the new Oncology Center of Excellence. He also serves as Director of the Oncology Program.

Dr. Kluetz continues to enjoy seeing patients and teaching medical house staff as an attending physician at the Georgetown University Hospital.

Stefan Larsson joined BCG in 1996. He is the global leader of BCG's Health Systems sector. Stefan is a BCG fellow and has focused his research on value-based health care.

He is a cofounder of ICHOM. Stefan has lead a large number of public and private projects on Value based Health care and its implications, most recently the "Value in Healthcare" project for the World Economic Forum.

Stefan is an MD, PhD and Associate professor at the Karolinska Institute (KI).

Besides KI Stefan trained at Harvard Medical School, MRC-Human Genetics Unit in Edinburgh and EMBL Heidelberg.

Professor Williams is Professor of Global Oral Health at Bart's and The London School of Medicine and Dentistry, Queen Mary University of London and Academic Lead for International Partnership. Previously he was Dean of the Faculty of Medicine, Health and Life Sciences and Professor of Pathology at the University of Southampton and then Vice Provost. He is currently Vice Chair of the FDI World Dental Federation Research Committee and Co-chair of the FDI Vision 2020 Think Tank. He is also Co-chair of the ICHOM International Consortium for Health Outcomes Measurement.

Dr. Williams was President of the International Association for Dental Research (IADR). During his Presidency, he was the driving force behind the IADR Global Oral Health Inequalities Research Agenda initiative. He was one of the founders of the IADR Global Oral Health Inequalities Research Network and its President from 2014-17.

Annelies Dekker is the Deputy Director Quality of PharmAccess Foundation. PharmAccess is a Dutch not-for-profit organization dedicated to improving access to better health care in Africa. PharmAccess mobilizes public and private resources for the benefit of doctors and patients through health insurance and other health financing products, loans to health care providers, quality standards and structured quality improvements, private investments and operational research. Among other PharmAccess developed in collaboration with the Joint Commission International (JCI, USA) and Cohsasa (South Africa) the only internationally acknowledged (ISQua) quality standards for resource poor settings. Since 2016 a collaboration started with ICHOM to develop a better understanding of how principles of value based health care can be applied in low and middle income countries to inform health systems worldwide. As a first step a pilot started to implement the ICHOM Pregnancy and Child Birth (PCB) Standard in the Kenyan health setting, using mobile solutions for scalable data collection.

Dr. Kim Dennis is a board-certified psychiatrist who specializes in treating eating disorders, substance use disorder, mood disorders and related trauma. She currently serves as the founder and CEO of SunCloud Health, an outpatient treatment center located in Highland Park which treats men and women, adolescents and adults. Dr. Kim's passion is in treating those who struggle with co-occurring disorders. Prior to founding SunCloud Health Dr. Dennis served as Medical Director and CEO at Timberline Knolls.

Dr. Dennis completed her psychiatry residency training at the University Of Chicago Hospitals, where she served as chief resident. During her training, she was part of the multi-disciplinary eating disorders team specializing in treating adolescents with eating disorders and their families.

She is a member of the American Medical Association, Academy for Eating Disorders, the American Academy of Addiction Psychiatry and the American Society for Addiction Medicine.

Jeff Hummel has been Qualis Health's Medical Director for Healthcare Informatics since 2006. His interests are integrating information technology into clinical workflows and measuring population health outcomes. Dr. Hummel is a general internist who began as a rural practitioner on the Washington-Idaho border. He spent 13 years at Group Health in Seattle implementing the chronic care model in a multi-disciplinary care team. He spent another 11 years at the University of Washington using EHR data for clinical quality reporting. He currently collaborates with Arcora, Inc. and Delta Dental developing clinical metrics for measuring population oral health status.

Dr Howard Ryland is training as a forensic psychiatrist in London. He was awarded a National Institute of Health Research Doctoral Training Fellowship to study outcome measurement in forensic psychiatry at the University of Oxford. He is President of the European Federation of Psychiatric Trainees. Previous roles include Chair of the Psychiatric Trainees' Committee at the Royal College of Psychiatrists and Clinic Leadership Fellow at the Academy of Medical Royal Colleges.

Andre Dias is head of Commercial and Regulatory Development at MYIA Labs where he is responsible for developing & implementing the commercial model, managing regulatory compliance, and providing oversight for R & D activities. Prior to MYIA, Andre was the VP of Strategy & New Program Development at the International Consortium for Health Outcomes Measurement where he led the build of the Global Outcomes Benchmarking Program. Additionally, he worked for a number of years as a strategy consultant focusing on technology, tele-communications and healthcare.

Mr. van Dijk is the Director of Prismant and co-founder and director of X-IS, labels of the Value2Health organization. X-IS is an organization that provides healthcare institutions with insight into the value of care (based on Michael Porter's value-based healthcare methodology) and helps them implement. Previously, he supervised scientific research on the relationship between quality and costs around the treatment of colorectal cancer (resulting in the Dutch Value-based Healthcare Study). He started his career as a consultant at KPMG, after which he switched to Performation and worked as product and project manager.

Barbara Jagels, RN, MHA, CPHQ. Vice President, Quality Safety & Value and Chief Quality Officer, Seattle Cancer Care Alliance. Barb Jagels has been with Seattle Cancer Care Alliance for 27 years and she is responsible for the operational planning, program quality, risk management, performance improvement, staff development and identification of capital needs. She has spent her career focusing on Oncology nursing care. She is a sitting member and former chair of the Comprehensive Cancer Care Consortium for Quality Improvement (C4QI) and is the former Chair and current Chair Emeritus of the Alliance of Dedicated Cancer Center's (ADCC) Quality Committee. Barb has worked closely with Centers for Medicare and Medicaid Services (CMS), University HealthSystem Consortium (UHC) and U. S. News &World Reports (USNWR) to develop more comprehensive oncology specific outcomes measures for national public reporting. Barb received her MHA in Public Health and Community Medicine from the University of Washington.

Colin Orr is a senior member of the ICON Innovation team with 20+ years' experience in the information technology industry delivering business intelligence, data warehousing and system integration solutions. Having spent the last 7 years working in the field of clinical research, Colin has developed a passion for healthcare with a particular focus on clinical and outcomes based research. Colin is the solution architect for the ICHOM Globe platform, an amalgamation of ICHOMs condition specific standard sets with the internationally recognized OMOP common data model (CDM) resulting in a solution that enables benchmarking of patient outcomes across the globe in a transparent way.

Mr. Sverdloff is a project management specialist, with vast experience in managerial activities of projects in multinational environments. Challenge driven, curious and open to new tecnologies and points of view. Mr. Sverdloff holds a Specialist Degree (Project Management), a MSc on Clinical Pharmacology and an extension course at Harvard Medical School (Principles and practice of Clinical Research). He is responsible for ICHOM standard sets implementation in Brazil.

Dr Charlotte Roberts is Vice-President for Standardisation at the International Consortium for Health Outcomes Measurement (ICHOM) where she leads the development of all Standard Sets of outcomes that matter most to people with different medical conditions. She joined ICHOM as a Project Leader in 2014 leading the development of the Dementia, Older Person, and Inflammatory Bowel Disease Standard Sets. Prior to joining ICHOM, Charlotte trained in Medicine and International Health at University College London and worked as a doctor in Oxford before completing a NHS National Medical Director's Clinical Fellowship in Medical Leadership and Management at Public Health England in 2013-14.

Dr Bos works as nephrologist at the St AntoniusHospital in Utrecht, the Netherlands. He chairs the ICHOM working group on Cronic Kidney Disease and is involved in VBHC projects for renal patients.

Samyra Keus is project lead Value Based Healthcare at OLVG hospital, part of the Santeon Group. She facilitates implementation of the improvement cycles by multidisciplinary VBHC teams dedicated to specific patient groups. VBHC@Santeon was awarded the VBHC Collaboration Award 2017. Samyra has a long track record of innovation of Parkinson's care, both national and international, including development of evidence-based guidelines, and co-creation of regional networks of dedicated healthcare professionals (ParkinsonNet, VBHC Prize 2015) and it's international scaling up (e.g. at Kaiser Permanente).

Martinus van de Laar is fully trained in Internal Medicine and Rheumatology. He is working as a consultant Rheumatologist at Arthritis Center Twente @ MST & @ University of Twente. His research experience is the patient's perspective including real life data and outcomes research. at his department innovative statistical techniques and computer technology are used to measure the patient's perspective and analyses outcomes over cultures, countries and diseases, supporting patients in becoming effective healthcare consumers; professionals to improve their care both in order to further improve value based healthcare.

Dr. Vonkeman is a trained rheumatologist and epidemiologist working at Medish Spectrum Twente and University of Twente in Enschede, The Netherlands. He serves as chair for the ICHOM international working group for Inflamamtory Arthritis.

Elizabeth Teisberg, co-creator of the idea of value-based health care strategy, serves as Executive Director of the Value Institute for Health and Care. The Value Institute creates curriculum for transforming strategy, culture and measurement in health care to improve health outcomes and reduce costs. Its translational research puts into practice thought-leading work on value-based health care delivery. The Value Institute also provides leadership for Dell Medical School's patient outcome measurement. An internationally recognized author and professor, Dr. Teisberg has won the Wachovia Award for outstanding research, the Frederick S. Morton Award for Leadership, and the Book of the Year Award from the American College of Health Care Executives.

Gail Eckhardt is a tenured Professor at the University of Texas at Austin's Dell Medical School where she is also the inaugural Director of the LIVESTRONG Cancer Institutes, Chair of the Department of Oncology, and Associate Dean of Cancer Programs. Prior to joining UT Austin, Dr. Eckhardt was Division Head of Medical Oncology at the University of Colorado School of Medicine; Associate Director for Translational Research at the University of Colorado Comprehensive Cancer Center and Director of the Phase I Program and Fellowship.

Dr. Eckhardt has served on numerous committees/study sections, including the ASCO Molecular Oncology Task Force, the ASCO Board of Directors, the FDA Oncology Drugs Advisory Committee, and the NCI Cancer Centers Study Section. She is a member of the NCI Investigational Drug Steering Committee and the NCI Colorectal Cancer Task Force, serves on seven External Advisory Boards of NCI designated Cancer Centers and is a mentor in ASCO's Leadership Development Program.

Capt. William Todd, executive officer of Naval Hospital Jacksonville and a fellowship-trained orthopedic surgeon, started out in law enforcement and later a paramedic. He's also a private pilot and was the No. 1 ranked operational flight surgeon for the Navy and Marine Corps. He has cared for war-wounded warriors at multiple military hospitals. He gave a TEDxPentagon Talk about compassion in the O.R. He has served with six Navy humanitarian missions with USNS Comfort, USNS Mercy, and USNS Spearhead. Todd published in the April 2017 NEJM Catalyst, "The Move to Value-Based Care in Navy Medicine."

Scott Wallace plays an influential part in the transformation of America's health delivery. He recently served as Interim Chief Business Officer of Dell Medical School, where he is an Associate Professor. Leveraging business and health policy backgrounds, Wallace was appointed by Pres. George W. Bush to chair the Federal Commission on Systemic Interoperability, created to advise the White House and Congress on health transformation through Information Technology. He has held a number of senior leadership positions – as CEO of a specialty chemical company, co-founder of a venture capital fund, CEO of the National Alliance for Health Information Technology, and a transactional attorney at Kirkland & Ellis. He is also a Batten Fellow at the University of Virginia's Darden School of Business, previously served on the faculty for Harvard Business School's health care strategy executive education program, and was a Distinguished Fellow at Dartmouth's Geisel School of Medicine.

Robert Makuch is a professor in the Department of Biostatistics at the Yale School of Public Health and Director of the Regulatory Affairs Track. Professor Makuch worked at the National Cancer Institute (NCI) and the World Health Organization's International Agency for Research on Cancer early in his career. He has served on numerous committees for the NCI and the National Institute of Allergy and Infectious Diseases and also worked closely with the Food and Drug Administration (FDA) and served as a Special Government Employee (SGE) to the FDA. In addition, Makuch developed a regulatory affairs track at YSPH for its students, and over the past 11 years has been the leader of numerous training programs for senior delegations of the Chinese Food and Drug Agency. Makuch was nominated to serve on the University of Connecticut Dean's Advisory Board for the College of Liberal Arts and Sciences.

Christine Jackson is a Sr. Director in the Global Health Policy, Reimbursement, and Health Economics Department at Medtronic. In this role, Christine works to shape Medicare payment policy for Medtronic devices, therapies, and services, with a specific focus on leading the policy analysis and development related to emerging payment models and other value-based health care initiatives. Christine also provides leadership to multiple business unit reimbursement teams on higher priority product issues and health policy concerns. In addition, Christine serves as a corporate liaison to the Latin American reimbursement council, providing coordination and guidance to the team in Latin America as part of the reimbursement function's global strategy.

Christine joined Medtronic in August 1997 and has served in various health policy and reimbursement roles throughout her years with the company, including roles in the Neuromodulation and Cardiac Rhythm Heart Failure management divisions. Christine started her career with Blue Cross Blue Shield of Minnesota.

Robert McGough works on Health Sector legal commercial and contractual issues for NHS/public sector organizations as well as independent providers both from the UK and internationally. He also provides legal advice on new integrated care pathway models and contractual structures for NHS and international healthcare organizations (including review of outcomes based arrangements and alliance contracting). Robert has advised on the development of alliance contracts for several clients including its first NHS use with NHS Lambeth, new collaborative arrangements for the 100k Genome Project and North Central London's innovative value based commissioning program. Robert is currently advising on accountable care organizations and systems for pathfinders in the NHS as well as supporting the development of pioneering value based approaches internationally.

Herb Riband leads Amgen's International Policy & Government Affairs work, focused on regions outside of the United States. In this capacity, he is responsible for anticipating and addressing the company's policy and government affairs needs across multiple jurisdictions, serving as a senior leader in Amgen's Global Value Access & Policy function. Previously, he led Amgen's Value Access & Policy function in Europe and co-led the launch of Amgen's Value-Based Health Care program in Europe. Mr. Riband is a member of the governing Council (Board) and Global Health Committee of Geneva-based IFPMA and serves on the Board of Directors of EBE and the International Committee of EFPIA. Prior to joining Amgen, Mr. Riband worked for Medtronic Inc., as Vice President External Affairs for Medtronic's International region, Mr. Riband also served as a member of the UK Ministerial Medical Technology Strategy Group and the Council for Multilateral Business Diplomacy.

A biochemist by education, Michael Seewald built expertise in analytical disciplines (biophysics, bioinformatics, chemoinformatics) during his academic career, and authored/co-authored publications in leading journals such as Nature and EMBO Journal. Michael began his industry career in the area of bioinformatics, then moved through a number of positions of increasing responsibility in Finance, Strategy, Marketing, and Development. Since 2015, Michael is heading the Center of Excellence for Real World Evidence at Novartis.

Ernst van Koesveld is Director Health Insurance as well as Deputy Director-General at the Ministry of Health, Welfare and Sport, the Netherlands. As a Director, he is responsible for various aspects of health insurance, notably entitlements, coverage, competition, risk equalization, co-payments and cost containment and the role of Insurance companies in the health care system. Prior to his current position, he held various positions at the Ministry of Finance, the UN Development Program in Lithuania and Vietnam, the Ministry of Economic Affairs and the Erasmus University. His background is in economics.

David Lansky, PhD, is the president and Chief Executive Officer of the Pacific Business Group on Health (PBGH). Lansky is the vice chair of the Health Care Transformation Task Force and is on the Guiding Committee of the HHS Learning and Action Network, the Congressional Budget Office Health Advisors Panel, and the Board of the Alliance for Health Reform.

Previously, Lansky was senior director of the Health Program at the Markle Foundation (NY), and he established the Foundation for Accountability (FACCT). He was a senior policy analyst for the Jackson Hole Group and led the Center for Outcomes Research and Education at Oregon-based Providence Health System. Lansky has served as a board member or advisor to numerous health care programs, including the National Quality Forum, federal Health IT Policy Committee, Catalyst for Payment Reform, Joint Commission, National Patient Safety Foundation, Leapfrog Group, and the Medicare Beneficiary Education Advisory Panel.

Stefano Scarpetta is Director for Employment, Labour and Social Affairs at the OECD since 2013. As director of ELS, he is responsible for the design and the implementation of the medium-term strategy of the Organisation on labour market and social policy issues as well as international migration and health issues. He represents the OECD in High-Level fora and academic conferences; liaise with key senior stakeholders and provide effective communication with the media. As a member of the Senior Management team of the Organisation, he also contributes to support and advance the strategic orientations of the OECD. Previously, he held several positions in the Economics Department and in his current Directorate. From 2002 to 2006 he also worked at the World Bank, where he took over the responsibility of labour market advisor and lead economist.

He has published extensively in academic journals, edited several books.